Хайлтын үр дүнгүүд - Eric Gauthier
- 13-н 1 - 13 үр дүнгүүдийг харуулж байна
-
1
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 Trial -н Véronique Dièras, Nadia Harbeck, Anil A. Joy, Karen A. Gelmon, Johannes Ettl, Sunil Verma, Dongrui R. Lu, Eric Gauthier, Patrick Schnell, A. Mori, Hope S. Rugo, Richard S. Finn
Хэвлэсэн 2019Artigo -
2
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer -н Chandrasekar Durairaj, Ana Ruiz‐García, Eric Gauthier, Xin Huang, Dongrui R. Lu, Justin T. Hoffman, Richard S. Finn, Anil A. Joy, Johannes Ettl, Hope S. Rugo, Jenny Zheng, Keith D. Wilner, Diane D. Wang
Хэвлэсэн 2018Artigo -
3
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer -н Richard S. Finn, Yuan Liu, Zhou Zhu, Miguel Martín, Hope S. Rugo, Véronique Dièras, Seock‐Ah Im, Karen A. Gelmon, Nadia Harbeck, Dongrui R. Lu, Eric Gauthier, Cynthia Huang Bartlett, Dennis J. Slamon
Хэвлэсэн 2019Carta -
4
Biomarker analyses from the phase 3 PALOMA-2 trial of palbociclib (P) with letrozole (L) compared with placebo (PLB) plus L in postmenopausal women with ER + /HER2– advanced breast... -н RS Finn, Yuqiu Jiang, Hope S. Rugo, SL Moulder, S.-A. Im, Karen A. Gelmon, Véronique Dièras, Miguel Martín, Anil A. Joy, Masakazu Toi, Eric Gauthier, Dongrui R. Lu, Cynthia Huang Bartlett, DJ Slamon
Хэвлэсэн 2016Artigo -
5
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breas... -н Richard S. Finn, Hope S. Rugo, Karen A. Gelmon, Massimo Cristofanilli, Marco Colleoni, Sherene Loi, Patrick Schnell, Dongrui R. Lu, Kathy Puyana Theall, A. Mori, Eric Gauthier, Eustratios Bananis, Nicholas C. Turner, Véronique Dièras
Хэвлэсэн 2021Artigo -
6
Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer -н Véronique Dièras, Hope S. Rugo, Patrick Schnell, Karen A. Gelmon, Massimo Cristofanilli, Sherene Loi, Marco Colleoni, Dongrui R. Lu, A. Mori, Eric Gauthier, Cynthia Huang Bartlett, Dennis J. Slamon, Nicholas C. Turner, Richard S. Finn
Хэвлэсэн 2018Artigo -
7
Sorafenib in patients with progressive epithelioid hemangioendothelioma -н Christine Chevreau, Axel Le Cesne, Isabelle Ray‐Coquard, Antoîne Italiano, Angela Cioffi, Nicolás Isambert, Y Robin, Charles Fournier, Stéphanie Clisant, L. Chaigneau, Jacques‐Olivier Bay, Emmanuelle Bompas, Eric Gauthier, Jean‐Yves Blay, Nicolas Penel
Хэвлэсэн 2013Artigo -
8
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up -н Hope S. Rugo, Richard S. Finn, Véronique Dièras, Johannes Ettl, O. N. Lipatov, Anil A. Joy, Nadia Harbeck, Aurelio Castrellon, Shrividya Iyer, Dongrui R. Lu, A. Mori, Eric Gauthier, Cynthia Huang Bartlett, Karen A. Gelmon, Dennis J. Slamon
Хэвлэсэн 2019Artigo -
9
Palbociclib and Letrozole in Advanced Breast Cancer -н Richard S. Finn, Miguel Martín, Hope S. Rugo, Stephen E. Jones, Seock‐Ah Im, Karen A. Gelmon, Nadia Harbeck, O. N. Lipatov, Janice M. Walshe, Stacy Moulder, Eric Gauthier, Dongrui R. Lu, Sophia Randolph, Véronique Dièras, Dennis J. Slamon
Хэвлэсэн 2016Artigo -
10
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study -н Seock-Ah Im, Hirofumi Mukai, In Hae Park, Norikazu Masuda, Chikako Shimizu, Sung-Bae Kim, Young-Hyuck Im, Shoichiro Ohtani, Cynthia Huang Bartlett, Dongrui R. Lu, Shrividya Iyer, Yuko Mori, A. Mori, Eric Gauthier, Richard S. Finn, Masakazu Toi
Хэвлэсэн 2019Artigo -
11
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer -н Dennis J. Slamon, Véronique Dièras, Hope S. Rugo, Nadia Harbeck, Seock‐Ah Im, Karen A. Gelmon, O. N. Lipatov, Janice M. Walshe, Miguel Martín, Mariana Chávez‐MacGregor, Eustratios Bananis, Eric Gauthier, Dongrui R. Lu, Sindy Kim, Richard S. Finn
Хэвлэсэн 2024Artigo -
12
Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO) -н Isabelle Ray‐Coquard, Antoîne Italiano, Emmanuelle Bompas, Axel Le Cesne, Y Robin, Christine Chevreau, Jacques‐Olivier Bay, Guilhem Bousquet, Sophie Piperno‐Neumann, Nicolás Isambert, L. Lemaître, Charles Fournier, Eric Gauthier, Olivier Collard, Didier Cupissol, Stéphanie Clisant, Jean‐Yves Blay, Nicolas Penel
Хэвлэсэн 2012Artigo -
13
Talazoparib in Patients with a Germline <i>BRCA</i>-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial -н Sara A. Hurvitz, Anthony Gonçalvès, Hope S. Rugo, Kyung-Hun Lee, Louis Fehrenbacher, Lida A. Mina, Sami Diab, Joanne L. Blum, Jayeta Chakrabarti, Mohamed Elmeliegy, Liza DeAnnuntis, Eric Gauthier, Akos Czibere, Iulia Cristina Tudor, Ruben G.W. Quek, Jennifer K. Litton, Johannes Ettl
Хэвлэсэн 2019Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Internal medicine
Medicine
Breast cancer
Cancer
Metastatic breast cancer
Oncology
Palbociclib
Letrozole
Gynecology
Tamoxifen
Chemotherapy
Confidence interval
Hazard ratio
Pathology
Alternative medicine
Clinical endpoint
Clinical trial
Estrogen receptor
Placebo
Adverse effect
Fulvestrant
Gastroenterology
Aromatase
Biochemistry
Biology
Biomarker
Discontinuation
Environmental health
Hepatocellular carcinoma
Neutropenia